研究报告 |
|
|
|
|
经NGR肽段遗传修饰的携带三种报告基因的腺病毒载体的构建及其实验研究 |
冯飞雪, 赵俊丽, 王东阳, 刘世海, 王丽娴, 夏海滨 |
陕西师范大学生命科学学院基因治疗研究室 西安 710062 |
|
Construction of NGR Peptide Genetically Modified Adenovirus Vector Expressing Three Reporter Genes and Its Experimental Study |
FENG Fei-xue, ZHAO Jun-li, WANG Dong-yang, LIU Shi-hai, WANG Li-xian, XIA Hai-bin |
Laboratory of Gene Therapy, College of Life Sciences, Shaanxi Normal University, Xi’an 710062,China |
引用本文:
冯飞雪, 赵俊丽, 王东阳, 刘世海, 王丽娴, 夏海滨. 经NGR肽段遗传修饰的携带三种报告基因的腺病毒载体的构建及其实验研究[J]. 中国生物工程杂志, 2011, 31(04): 25-30.
FENG Fei-xue, ZHAO Jun-li, WANG Dong-yang, LIU Shi-hai, WANG Li-xian, XIA Hai-bin. Construction of NGR Peptide Genetically Modified Adenovirus Vector Expressing Three Reporter Genes and Its Experimental Study. China Biotechnology, 2011, 31(04): 25-30.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/
或
https://manu60.magtech.com.cn/biotech/CN/Y2011/V31/I04/25
|
[1] Rittner K,Schreiber V,Erbs P,et al. Targeting of adenovirus vectors carrying a tumor cell-specific peptide: in vitro and in vivo studies. Cancer Gene Ther,2007,14(5):509-518.
[2] Belousova N,Krendelchtchikova V,Curiel D T,et al. Modulation of adenovirus vector tropism via incorporation of polypeptide ligands into the fiber protein. J Virol,2002,76(17):8621-8631.
[3] Mizuguchi H,Koizumi N,Hosono T,et al. A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knob. Gene Therapy,2001,8(9):730-735.
[4] Pasqualini R,Koivunen E,Kain R,et al. Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis. Cancer Res,2000,60(3):722-727.
[5] Riemann D,Kehlen A,Langner J. CD13——not just a marker in leukemia typing. Immunol Today,1999,20(2):83-88.
[6] Corti A,Curnis F,Arap W,et al. The neovasculature homing motif NGR: more than meets the eye. Blood,2008,112(7):2628-2635.
[7] Xia H,Anderson B,Mao Q,et al. Recombinant human adenovirus: targeting to the human transferrin receptor improves gene transfer to brain microcapillary endothelium. J Virol,2000,74(23):11359-11366.
[8] Liu S,Mao Q,Zhang W,et al. Genetically modified adenoviral vector with the protein transduction domain of Tat improves gene transfer to CAR-deficient cells. Biosci Rep,2009,29(2):103-109.
[9] Santoro A,Rimassa L,Sobrero A F,et al. Phase II study of NGR-hTNF, a selective vascular targeting agent, in patients with metastatic colorectal cancer after failure of standard therapy. Eur J Cancer,2010,46(15):2746-2752.
[10] Spitaleri A,Mari S,Curnis F,et al. Structural basis for the interaction of isoDGR with the RGD-binding site of αvβ3 integrin. J Biol Chem,2008,283(28):19757-19768.
[11] Jullienne B,Vigant F,Muth E,et al. Efficient delivery of angiostatin K1-5 into tumors following insertion of an NGR peptide into adenovirus capsid. Gene Ther,2009,16(12):1405-1415.
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|